Netscribes' latest market research report titled Coronary Stents Market in India 2014 states that manufacturers of coronary stents are experiencing high demand for their products due to a number of reasons. With cardiovascular diseases becoming a common occurrence amongst Indians and the healthcare infrastructure in the country rapidly improving, the number of angioplasty procedures being carried out in the country has increased significantly. Advancements in technology has resulted in patients being more receptive towards stent implants. The products available in the market can be divided into two types - those manufactured by MNCs and commanding high prices, and those manufactured by domestic companies and generally having lower prices. The general perception is that stents manufactured by MNCs are superior in terms of quality and efficacy whereas those manufactured by domestic companies fail to attain similar high quality. As a result, the MNCs serve majority of the market with almost all the big hospitals in tier I cities preferring to implant stents manufactured by foreign companies. Since the medical equipments and devices industry in India has not been given any separate legal status and coronary stents have been classified as drugs under the provisions of the Drugs & Cosmetics Act, 1940, the Central Drugs Standard Control Organization (CDSCO) is responsible for the regulation of stents in the country. The significant reduction in reimbursement rates for stents under the Central Government Health Scheme (CGHS) in Feb 2013 and a further reduction in the reimbursement rates in Apr 2014 has badly affected manufacturers, especially the MNCs. Although majority of the angioplasties performed in the country are done in private establishments with only a few being done under the CGHS, the reduction in the reimbursement rates is likely to force companies to lower price in the open market as well. However, despite a fall in price of products, the market is still expected to grow steadily. Moreover, the penetration of cath labs in the smaller cities and towns has made angioplasty more accessible to patients and is expected to boost demand for stents.
Table of Contents
Slide 1: Executive Summary Macroeconomic Indicators Slide 2: GDP at Factor Cost: Quarterly (2010-11, 2011-12, 2012-13, 2013-14), Inflation Rate: Monthly (Jul 2013 - Dec 2013) Slide 3: Gross Fiscal Deficit: Monthly (Feb 2013 - Jul 2013), Exchange Rate: Half Yearly (Oct 2013 - Mar 2014) Slide 4: Lending Rate: Annual (2008-09, 2009-10, 2010-11, 2011-12), Trade Balance: Annual (2010-11, 2011-12, 2012-13, 2013-14), FDI: Annual (2009-10, 2010-11, 2011-12, 2012-13) Introduction Slide 5: Coronary stents - Uses, Characteristics and Types Slide 6: Development of Coronary Stents Market Overview Slide 7: Angioplasties - Overview and Number of Procedures Performed in India (2008 - 2018e) Slide 8: Angioplasties - Segmentation (Age-Wise; 2008 - 2013 & Gender-Wise; 2008 -2013) Slide 9: Angioplasties - Segmentation (Based on Vessels Treated; 2009 - 2013 & Segregation of Centers Based on Number of Angioplasties Performed Each Year; 2009, 2010, 2011, 2013) Slide 10: Coronary Stents - Market Overview, Market Size & Growth (Value-Wise; 2012 - 2018e & Volume-Wise; 2012 - 2018e) Slide 11: Drug-Eluting Stents - Market Overview, Market Size & Growth (Value-Wise; 2012 - 2018e & Volume-Wise; 2012 - 2018e) Slide 12: Bare Metal Stents - Market Overview, Market Size & Growth (Value-Wise; 2012 - 2018e & Volume-Wise; 2012 - 2018e) Slide 13: Bioabsorbable Stents - Market Overview, Market Size & Growth (Value-Wise; 2013 - 2018e & Volume-Wise; 2013e - 2018e) Slide 14: Coronary Stents - Price Trends Drivers & Challenges Slide 15: Drivers and Challenges - Summary Slide 16-20: Drivers Slide 21-22: Challenges Government Involvement Slide 23: Organizational Structure of Regulatory Bodies Slide 24-25: Regulatory Bodies Slide 26-29: Regulatory Policies Slide 30: Process of Obtaining License for Manufacturing Medical Device Regulated as Drugs in India Slide 31-33: Requirements for Grant of License for Manufacture of Medical Devices in India Slide 34: Process of Obtaining Registration for Import of Medical Device Regulated as Drugs in India Slide 35-39: Documents Required for the Registering Medical Devices for Import into India Competitive Landscape Slide 40-42: Entry Barriers Slide 43: Porter's Five Forces Analysis Slide 44: Competition Overview, Market Share of Companies (Volume-Wise; 2013) Slide 45: Sale of Coronary Stents by Various Companies (2013) Slide 46-49: Competitive Benchmarking Slide 50-98: Major Companies Buyer Details Slide 99: List of Top 10 Hospitals Buying Coronary Stents in India Slide 100-129: Major Buyers Slide 130: Other Major Purchasers of Stents Recent Developments Slide 131: Major Recent Developments in the Market Strategic Recommendation Slide 132-133: Key Recommendations Slide 134: Opportunities by Geography Appendix Slide 135: Key Ratios Description Slide 136: Sources of Information
List of Tables
Market Overview 1. Coronary Stents - Price Trends Government Involvement 1. Reimbursement Rates Under Central Government Health Scheme (2007, 2011, 2013) Competitive Landscape 1. Coronary Stents Sale (Company-Wise; 2013) 2. Company Profiles (All Companies) a. Company Information (All Companies) b. Products and Services (All Companies) c. Key People (All Companies) d. Shareholders of the Company (Private Companies) e. Key Financial Performance Indicators (Public Companies) f. Key Ratios (Except Boston Scientific India Pvt. Ltd.) g. Business Highlights (All Companies) Buyer Details 1. Top 10 Hospitals Buying Coronary Stents In India 2. Buyer Profiles (All Companies) a. Company Information (All Companies) b. Products and Services (All Companies) c. Key People (All Companies) d. Business Highlights (All Companies) e. Key Hospital Indicators f. Stent Procurement Procedure 3. Other Major Hospitals Buying Coronary Stents In India 4. Appendix 1. Key Ratios Description 2. Sources of Information
Our library has over 100000 reports on 1000s of topics
Over 100+ Fortune 500 companies rely on us
90,000+ people come to us for insights every month
Toll Free: 1-888-928-9744
Email: [email protected]
Speak to the report author to design an exclusive study to serve your research needs.
A testimonial for service excellence represented in the form of BBB "A" Accreditation.
Your personal and confidential information is safe and secure.